Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448207) titled 'Association Between Extremity Muscle Strength and Functional Outcomes in Chil... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448363) titled 'Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica' on... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449026) titled 'Interrater Reliability and Feasibility of the Lasater Clinical Judgment Rubri... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449624) titled 'From Presentation to Diagnosis: Patterns of Pleural Effusion' on Feb. 26. St... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449702) titled 'An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psorias... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449845) titled 'Quality of Life Assessment in Patients With Epilepsy Using QOLIE-31' on Feb. ... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07450261) titled 'Effectiveness of Instrumental Assisted Soft Tissue Mobilization Versus Conven... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07450859) titled 'A Study of BT5528 in Patients With Metastatic Pancreatic Ductal Adenocarcinom... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07451301) titled 'Serum Anti-enteric Neuronal Antibodies in Patients With Achalasia and Their A... Read More
Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07454226) titled 'ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL' on Feb. ... Read More